The F-1 effectiveness means Scinai can now sell securities under the shelf or proceed with a priced offering. Watch for a prospectus supplement or 424B filing to reveal offering size and pricing, which typically follows within 1-2 days.
Price Chart
Executive Summary
The SEC declared effective Scinai Immunotherapeutics Ltd.'s F-1 registration statement (File No. 333-299112) on October 5, 2026, under the 1933 Act. This allows the company to proceed with a securities offering, likely a follow-on or shelf offering, creating potential dilution overhang for existing shareholders. The filing does not disclose the offering size, pricing, or specific terms.
Key Facts
- Effectiveness date: October 5, 2026
- Registration statement type: F-1 (foreign issuer primary offering)
- SEC File Number: 333-299112
- No offering size, pricing, or terms disclosed in the EFFECT notice
- Company is a clinical-stage biotech (SIC 2836) with no disclosed revenue or profitability data in this filing
Financial Impact
Undisclosed amount — potential dilution from an F-1 offering; no specific dollar figures provided
Risk Factors
- Potential immediate dilution from share issuance without disclosed terms
- No financial data in this filing — uncertainty about offering size and use of proceeds
- Clinical-stage biotech with no product revenue; dilution risk is material
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003155 |
| Document: 9999999995-26-003155-index.html | 9999999995-26-003155 |
| Document: 9999999995-26-003155.txt | 9999999995-26-003155 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 6-K | $0.6813 | awaiting T+60 | — | $0.5420 (−20.45%) |
Oct 16, 2026 10d ago | 6-K | $0.7520 | awaiting T+60 | — | $0.5420 (+27.93%) |
Oct 16, 2026 11d ago | Press Release | $0.7524 | awaiting T+60 | — | $0.5420 (+27.96%) |
Oct 15, 2026 11d ago | 6-K | $0.9015 | awaiting T+60 | — | $0.5420 (+39.88%) |
Oct 13, 2026 14d ago | 6-K | $1.23 | awaiting T+60 | — | $0.5420 (−55.93%) |
Oct 6, 2026 21d ago | EFFECT | $1.22 | awaiting T+60 | — | $0.5420 (+55.57%) |
Sep 21, 2026 5w ago | 6-K | $1.69 | awaiting T+60 | — | $0.5420 (−67.93%) |
Aug 26, 2026 8w ago | 6-K | $2.87 | awaiting T+60 | — | $0.5420 (+81.11%) |
Aug 19, 2026 9w ago | 6-K | $0.2740 | awaiting T+60 | — | $0.5420 (−97.81%) |
Jun 17, 2026 18w ago | 6-K | $0.3370 $0.2440 | ▼ −27.60% | ▼ −30.28% | $0.5420 (+60.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers